No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
10-Q: Q3 2024 Earnings Report
10-Q/A: Quarterly report (Amendment)
Express News | PowerUp Acquisition Corp - Aspire Biopharma Valued at Approximately $316 Million
Aspire Biopharma, Inc., and PowerUp Acquisition Corp. Announce Business Combination Agreement to Create Nasdaq-listed Biopharmaceutical Company Driving Breakthrough Innovations in FDA Approved Drugs, Nutraceuticals and Supplements
Express News | PowerUp Acquisition: Aspire's Stockholders to Get Shares of Combined Co's Common Stock Equal to $316.8 Mln Less
10-Q: Q2 2024 Earnings Report
Unlock the Full List